Literature DB >> 19449431

Phenotypic variability in trisomy 13 mosaicism: two new patients and literature review.

Christopher B Griffith1, Gail H Vance, David D Weaver.   

Abstract

Trisomy 13 mosaicism occurs when two cell lines, one with a normal complement of chromosomes and the other with an additional chromosome 13, are present in the same individual. We present two children with trisomy 13 mosaicism and summarize the literature in 47 published cases. Our first patient is a 4-year-old male with normal development and dysmorphic features that include right microtia, tall forehead, bulbous nose, and high arched palate. The second patient died at 1 day of life secondary to laryngeal stenosis, a previously undocumented finding in trisomy 13. His other dysmorphic features included micrognathia, cleft soft palate, and an axillary pterygium. Several published case reports of patients with trisomy 13 mosaicism have had the typical phenotype of complete trisomy 13 with death in the neonatal period, while others have had few dysmorphic features and prolonged survival. The most common malformations in all 49 cases included ear anomalies, cleft lip and palate, and various congenital heart defects. Intelligence varied from normal in six patients to significant delays and mental retardation in the remainder of cases. There is no clear correlation between the percentage of trisomic cells and the level of intellectual function. The dysmorphic features seen vary considerably from one patient to the next, often making the clinical diagnosis of trisomy 13 mosaicism difficult. In counseling families, medical professionals should state that trisomy 13 mosaicism may lead to physical abnormalities and poor intellectual outcomes, but that the condition does not do so universally with normal development occurring in some individuals. (c) 2009 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2009        PMID: 19449431     DOI: 10.1002/ajmg.a.32883

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  13 in total

Review 1.  Genetic Advances in the Understanding of Microtia.

Authors:  Craig Gendron; Ann Schwentker; John A van Aalst
Journal:  J Pediatr Genet       Date:  2016-09-23

2.  Occurrence and clinical features of epileptic and non-epileptic paroxysmal events in five children with Pallister-Killian syndrome.

Authors:  Francis M Filloux; John C Carey; Ian D Krantz; Jeffrey J Ekstrand; Meghan S Candee
Journal:  Eur J Med Genet       Date:  2012-02-01       Impact factor: 2.708

Review 3.  Constitutional and acquired autosomal aneuploidy.

Authors:  Colleen Jackson-Cook
Journal:  Clin Lab Med       Date:  2011-12       Impact factor: 1.935

Review 4.  Microtia: epidemiology and genetics.

Authors:  Daniela V Luquetti; Carrie L Heike; Anne V Hing; Michael L Cunningham; Timothy C Cox
Journal:  Am J Med Genet A       Date:  2011-11-21       Impact factor: 2.802

5.  Mosaic trisomy 13 and a sacral appendage.

Authors:  Harry Pachajoa; Luis Enrique Meza Escobar
Journal:  BMJ Case Rep       Date:  2013-07-31

6.  Inheritance of a t(13;14)(q10;q10) Robertsonian translocation with a low level of trisomy 13 mosaicism.

Authors:  Jutta Jenderny; Winfried Schmidt; Oliver Bartsch
Journal:  Eur J Pediatr       Date:  2009-12-03       Impact factor: 3.183

7.  A newborn with trisomy 13 who had tetralogy of Fallot and metopic synostosis: Case report.

Authors:  M Karabel; I Yolbaş; S Kelekçi; V Sen; Yk Haspolat; L Timuroğlu
Journal:  Hippokratia       Date:  2013-07       Impact factor: 0.471

Review 8.  Development of patients with 47,XX,+13/45,X mosaics: case report and review of the literature.

Authors:  Hao-Wei Tang; Su-Fen Liao; Jyun-Sian Li
Journal:  Eur J Pediatr       Date:  2013-05-12       Impact factor: 3.183

9.  Complete trisomy 14 mosaicism: first live-born case in Korea.

Authors:  Yun Jung Hur; Taegyu Hwang
Journal:  Korean J Pediatr       Date:  2012-10-29

10.  Non-invasive prenatal detection of trisomy 13 using a single nucleotide polymorphism- and informatics-based approach.

Authors:  Megan P Hall; Matthew Hill; Bernhard Zimmermann; Styrmir Sigurjonsson; Margaret Westemeyer; Jennifer Saucier; Zachary Demko; Matthew Rabinowitz
Journal:  PLoS One       Date:  2014-05-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.